Kinnate Biopharma (KNTE)
NASDAQ:KNTE

Kinnate Biopharma (KNTE) Similar Stocks

232 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Kinnate Biopharma
$125.15M
-1.09
-56.56%
0 Buy
2 Hold
0 Sell
Hold
$2.00
RAPT Therapeutics
$274.90M
-2.59
-51.50%
4 Buy
5 Hold
0 Sell
Moderate Buy
$15.60
G1 Therapeutics
$249.51M
-5.02
91.20%
4 Buy
0 Hold
1 Sell
Moderate Buy
$8.33
Crispr Therapeutics AG
$5.30B
-31.91
39.50%
10 Buy
6 Hold
2 Sell
Moderate Buy
$78.31
Oncternal Therapeutics
$25.60M
-0.64
53.10%
2 Buy
1 Hold
0 Sell
Moderate Buy
$27.50

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
KNTE
Kinnate Biopharma
2.65
-0.10
-3.64%
RAPT
RAPT Therapeutics
7.90
-15.14
-65.71%
GTHX
G1 Therapeutics
4.78
2.42
102.54%
CRSP
Crispr Therapeutics AG
62.90
7.46
13.46%
ONCT
Oncternal Therapeutics
8.65
0.55
6.79%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis